Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7542860 | 1.00 | NAAA (0.50) | NAAATSHRPPARGSLC5A1RAD52 | |
| Decane SCHEMBL8084226 | 0.80 | SLC5A1 (0.46) | NAAASLC5A1ALDH1A1 | |
| Hexadecane SCHEMBL8144910 | 0.80 | SLC5A1 (0.46) | NAAASLC5A1ALDH1A1 | |
| SCHEMBL21494420 | 0.80 | NAAA (0.47) | NAAATSHRPPARGEPHX1ALDH1A1 | |
| SCHEMBL13610178 | 0.78 | PPARG (0.45) | NAAATSHRPPARGALDH1A1LMNA | |
| SCHEMBL16330102 | 0.77 | NAAA (0.47) | NAAATSHRPPARGEPHX1GPR84 | |
| SCHEMBL1298171 | 0.76 | NAAA (0.53) | NAAATSHRPPARGRAD52NPSR1 | |
| SCHEMBL1297758 | 0.76 | NAAA (0.53) | NAAATSHRPPARGRAD52NPSR1 | |
| SCHEMBL22361227 | 0.76 | NAAA (0.59) | NAAATSHRPPARGRAD52NPSR1 | |
| SCHEMBL1297645 | 0.76 | NAAA (0.53) | NAAATSHRPPARGRAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106999446-A | Oxapigenin patch | 纽罗德姆有限公司 | 2017-08-01 | — | — | CN | claimed |
| US-20020019055-A1 | NON-INVASIVE TRANSDERMAL DETECTION OF ANALYTES | TRANSDERM TECHNOLOGIES LLC | 2002-02-14 | — | — | US | claimed |
| WO-2020131915-A1 | USE OF OLANZAPINE FOR TREATMENT OF PARP-INHIBITOR-INDUCED NAUSEA | STARTON THERAPEUTICS, INC. (US) | 2020-06-25 | — | — | WO | disclosed |
| CN-108778244-A | DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF | DFB索里亚有限责任公司 | 2018-11-09 | — | — | CN | disclosed |
| CN-106999446-A | Oxapigenin patch | 纽罗德姆有限公司 | 2017-08-01 | — | — | CN | disclosed |
| EP-3082845-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES | University Of Manitoba (CA) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015089664-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES | UNIVERSITY OF MANITOBA (CA) | 2015-06-25 | — | — | WO | disclosed |
| US-6492180-B2 | EXTRACTION THROUGH THE SKIN OR HAIR USING A 2-PYRROLIDONE IN A CARRIER; DRUGS OF ABUSE, CAFFEINE, PRESCRIPTION DRUGS, E.G. ACETAMINOPHEN, METABOLIC ANALYTES, E.G., BLOOD GLUCOSE AND HEAVY METALS, E.G. LEAD, LITHIUM, COPPER AND IRON | TRANSDERM TECHNOLOGIES LLC | 2002-12-10 | — | — | US | disclosed |
| EP-1090301-B1 | NON-INVASIVE TRANSDERMAL DETECTION OF ANALYTES | TRANSDERM TECHNOLOGIES LLC (US) | 2002-07-31 | — | — | EP | disclosed |
| US-20020019055-A1 | NON-INVASIVE TRANSDERMAL DETECTION OF ANALYTES | TRANSDERM TECHNOLOGIES LLC | 2002-02-14 | — | — | US | disclosed |